After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
B. Braun Medical Inc. is recalling over 60 000 containers of 0.9% sodium chloride injection for the potential presence of particulate matter and fluid leakage.
B. Braun Medical Inc. is recalling over 60 000 containers of 0.9% sodium chloride injection for the potential presence of particulate matter and fluid leakage.
Hikma Pharmaceuticals USA Inc. is recalling over 30 000 bags of acetaminophen injection after a bag labeled dexmedetomidine HCl injection was found inside an overwrap labeled acetaminophen injection.
Hikma Pharmaceuticals USA Inc. is recalling over 30 000 bags of acetaminophen injection after a bag labeled dexmedetomidine HCl injection was found inside an overwrap labeled acetaminophen injection.
Aurobindo Pharma USA Inc., on behalf of AuroHealth, is recalling bottles of Healthy Living migraine relief tablets because bottles sold through Amazon are missing the manufacturer’s label, including drug fact information.
Aurobindo Pharma USA Inc., on behalf of AuroHealth, is recalling bottles of Healthy Living migraine relief tablets because bottles sold through Amazon are missing the manufacturer’s label, including drug fact information.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
Taro Pharmaceuticals USA Inc. is recalling vials of hydrocortisone and acetic acid otic solution for failing to meet impurity and degradation specifications.
Taro Pharmaceuticals USA Inc. is recalling vials of hydrocortisone and acetic acid otic solution for failing to meet impurity and degradation specifications.
Dr Reddy’s Laboratories Inc. is recalling cartons of sevelamer carbonate for oral suspension because the packets are missing lot numbers and expiration dates.
Dr Reddy’s Laboratories Inc. is recalling cartons of sevelamer carbonate for oral suspension because the packets are missing lot numbers and expiration dates.
The integration of artificial intelligence (AI) into solid organ transplantation holds significant promise, as AI can potentially revolutionize the field by improving risk assessment, organ allocation, and post-transplant outcomes, according...
The integration of artificial intelligence (AI) into solid organ transplantation holds significant promise, as AI can potentially revolutionize the field by improving risk assessment, organ allocation, and post-transplant outcomes, according...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
After a patient receives a solid organ transplant, long-term nutrition management is key to navigate potential adverse events from immunosuppressive therapies needed to prevent rejection, according to an invited review article published in...
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Amid changing guidelines from the Centers for Disease Control and Prevention, pharmacies are denying fourth COVID-19 shots to patients with weakened immune systems.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.
Compared to standard basiliximab-based induction therapy, treatment based on alemtuzumab reduces rejection in kidney transplant recipients, according to findings from a UK-based study.